2022. Efficacy and Clinical Outcomes of Remdesivir Plus Intravenous Cefepime Compared to Remdesivir Plus Intravenous Levofloxacin in Type 2 Diabetes Mellitus Iraqi Patients with COVID -19. Journal of Pharmaceutical Negative Results. 13, 2 (Jun. 2022), 82–86.